Press Releases

PaizaBio’s Message for J.P. Morgan Week? China Is Open for Business

ALBUQUERQUE, New Mexico (January 5, 2017) – As thousands of life sciences executives and investors descend on San Francisco for the 35th Annual J.P. Morgan Healthcare Conference next week, PaizaBio has a simple message: China, the world’s second…


PaizaBio Opens Enrollment to December Aseptic Training Seminar in Hangzhou, China

ALBUQUERQUE, New Mexico (U.S.) (October 9, 2016) – The Chinese FDA has made it clear via mandates that China’s burgeoning biopharmaceutical industry must meet cGMP and GXP manufacturing standards if they are to compete globally. To provide the…


PaizaBio Receives CFDA Approval to Expand Fill-and-Finish CMO In China

ALBUQUERQUE, New Mexico (U.S.) (October 3, 2016) – – PaizaBio today announced it has secured approval from China’s FDA (CFDA) to add new aseptic injectable production capability at it production facility in Hangzhou, China. This expansion will increase…


China Approves Drug Marketing Authorization Holder Pilot Plan, Green Lights Pharmaceutical Contract Manufacturing Sector

ALBUQUERQUE, N.M., USA (June 19, 2016) – China’s State Council issued an effective notice dated May 26, 2016, formally authorizing a trial plan for a new Drug Marketing Authorization Holder (MAH) System for ten provinces: Beijing, Tianjin, Hebei,…


Taiwan-Based JHL Biotech Selects PaizaBio to Provide Fill-and-Finish CMO Services for Groundbreaking Therapies

ALBUQUERQUE, New Mexico, USA (May 17, 2016) – PaizaBio, Inc., has secured an agreement with Taiwan-based JHL Biotech, Inc. (Stock Code: 6540.TWO) to provide fill-finish services for multiple JHL projects. New Mexico-based PaizaBio will provide these services to…


PaizaBio’s Deere to Address Pharma China Annual Forum in Shanghai

ALBUQUERQUE, N.M. (February 25, 2016) – As China celebrates the Year of the Red Fire Monkey, whose presence portends an auspicious year of reinvention, the world’s second largest economy is facing an overhaul of its healthcare system and…


Sterile University to Train Drug Manufacturing Workforce in China

ALBUQUERQUE, N.M. (January 19, 2016) – In the wake of the Chinese cFDA’s new policies announced December 1, 2015, expanding opportunities for in-country contract drug manufacturing, PaizaBio and partner Complya Asia have established a formal technical education program…


Major Regulatory Policy Changes in China Will Impact Western Drug Development and Manufacturing Strategies

ALBUQUERQUE, N.M., December 9, 2015 – – China’s Food and Drug Administration (cFDA) has recently published long anticipated reforms designed to accelerate the regulatory review of new drugs and expand options for manufacturing those approved. According to PaizaBio,…


PaizaBio CEO a Featured Presenter at 2015 China National Science and Technology Cooperation Week

ALBUQUERQUE, N.M., November 23, 2015 – PaizaBio Founder and CEO Stuart Rose is a featured speaker at the 2015 China National Science and Technology Cooperation Week December 11-13 in Dongguan City, Guandong Province. Rose is the guest of…


PaizaBio Debuts at CPhI Worldwide in Madrid

ALBUQUERQUE, N.M., October 7, 2015 – PaizaBio, a contract manufacturing organization (CMO) that provides Western pharmaceutical companies with rapid access to China’s rapidly growing sterile injectables market, will debut next week at CPhI Worldwide in Madrid, Spain, which…